Sincrolab is a company dedicated to the design and commercialization of technological tools for the neuropsychological rehabilitation of patients with neurodevelopmental disorders. It offers an Artificial Intelligence digital prescription neuro medicine based on videogames delivered through mobile devices.
Sincrolab is a platform aimed at the recovery and development of cognitive abilities. Consists of personalized, standardized, and scientifically validated cognitive stimulation training focused on the educational and health field. We believe that technology can help to democratize health, and more specifically, mental health. We believe we can help reorganize network connectivity in the brain through technology. Our main goal is to enable rehabilitation instruments for all those who need them. We design and develop technological tools for the treatment of patients with Developmental Disorders and Neurological Disorders, through Artificial Intelligence, intuitive, accurate, innovative, and scientifically validated.
Total Funding: $117,000
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2013
